In vitro antifungal susceptibilities of trichosporon species

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 4, 2002, Pages 1144-1146

  Paphitou, Niki I ^a   Ostrosky Zeichner, Luis ^a   Paetznick, Victor L ^a   Rodriguez, Jose R ^a   Chen, Enuo ^a   Rex, John H ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; POSACONAZOLE; PYRROLE DERIVATIVE; RAVUCONAZOLE; VORICONAZOLE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DILUTION; DRUG POTENCY; FUNGAL STRAIN; FUNGICIDAL ACTIVITY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TRICHOSPORON;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; AZOLES; MICROBIAL SENSITIVITY TESTS; TRICHOSPORON;

EID: 0036208930     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.4.1144-1146.2002     Document Type: Article

References (21)

1. Disseminated trichosporonosis: Meeting the challenge
2. Emerging fungal pathogens
3. Trichosporon beigelii infection: Experience in a regional burn center
4. Trichosporon asahii, a non-candida yeast that caused fatal septic shock in a patient without cancer or neutropenia
5. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts
6. Neotypification of the genus Trichosporon
7. In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum
8. Trichosporon beigelii infection: A review
9. Invasive yeast infections other than Candida spp. in acute leukaemia
10. Transmission of Trichosporon asahii oesophagitis by a contaminated endoscope
11. In vitro activity of voriconazole against selected fungi
12. A case of Trichosporon beigelii endocarditis
13. Trichosporon species infection in bone marrow transplanted patients
14. In vitro susceptibility of yeasts for fluconazole and itraconazole. Evaluation of a microdilution test
15. In vitro susceptibility of Trichosporon beigelii to antifungal agents
16. In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens
17. Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading
18. Trichosporonosis
19. Trichosporon beigelii, an emerging pathogen resistant to amphotericin B
20. Experimental disseminated trichosporonosis in mice: Tissue distribution and therapy with antifungal agents